Get startedLog in
    Picture of Novakand Pharma AB logo

    NOVKAN — Novakand Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Kancera: positive results with fractalkine blocker KAN0440567 in preclinical models of pain caused by anti-cancer drugs

    Picture of Novakand Pharma AB logoNovakand Pharma AB
    19/12/2016 07:33
    Dec 19 (Reuters) - Kancera AB  KANC.ST : 
    * Reports positive results with fractalkine blocker KAN0440567 in preclinical models of pain 
caused by anti-cancer drugs 
 
     
Source text for Eikon:  ID:nWkrls4559  
     
Further company coverage:  KANC.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Novakand Pharma AB

    See all news